Related Experiment Videos
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Yetao Jin1, Hunjoo Lee, Shelya X Zeng
1Department of Biochemistry and Molecular Biology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Abstract:
The CDK inhibitor p21waf1/cip1 is degraded by a ubiquitin-independent proteolytic pathway. Here, we show that MDM2 mediates this degradation process. Overexpression of wild-type or ring finger-deleted, but not nuclear localization signal (NLS)-deleted, MDM2 decreased p21waf1/cip1 levels without ubiquitylating this protein and affecting its mRNA level in p53(-/-) cells. This decrease was reversed by the proteasome inhibitors MG132 and lactacystin, by p19(arf), and by small interfering RNA (siRNA) against MDM2. p21waf1/cip1 bound to MDM2 in vitro and in cells. The p21waf1/cip1-binding-defective mutant of MDM2 was unable to degrade p21waf1/cip1. MDM2 shortened the half-life of both exogenous and endogenous p21waf1/cip1 by 50% and led to the degradation of its lysine-free mutant. Consequently, MDM2 suppressed p21waf1/cip1-induced cell growth arrest of human p53(-/-) and p53(-/-)/Rb(-/-)cells. These results demonstrate that MDM2 directly inhibits p21waf1/cip1 function by reducing p21waf1/cip1 stability in a ubiquitin-independent fashion.
Insights
MDM2 directly degrades the CDK inhibitor p21waf1/cip1 via a ubiquitin-independent pathway. This process reduces p21waf1/cip1 stability, inhibiting cell growth arrest in cancer cells lacking p53.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- p21waf1/cip1 is a key cyclin-dependent kinase (CDK) inhibitor regulating cell cycle progression.
- The degradation of p21waf1/cip1 is crucial for cell cycle control, but the underlying mechanisms are not fully elucidated.
- MDM2 is known as an E3 ubiquitin ligase and a negative regulator of p53.
Purpose of the Study:
- To investigate the role of MDM2 in the degradation of p21waf1/cip1.
- To determine if MDM2 mediates p21waf1/cip1 degradation through a ubiquitin-independent pathway.
- To elucidate the functional consequences of MDM2-mediated p21waf1/cip1 degradation on cell growth.
Main Methods:
- Utilized p53-null cells and p53-null/Rb-null cells.
- Employed overexpression of wild-type and mutant MDM2 (ring finger-deleted, NLS-deleted, p21waf1/cip1-binding-defective).
- Applied proteasome inhibitors (MG132, lactacystin) and siRNA against MDM2.
- Performed in vitro and in-cell binding assays.
- Assessed protein half-life and degradation of lysine-free mutants.
Main Results:
- MDM2 overexpression reduced p21waf1/cip1 levels without ubiquitylation or affecting its mRNA.
- MDM2-mediated degradation was reversed by proteasome inhibitors, p19arf, and MDM2 siRNA.
- p21waf1/cip1 directly bound to MDM2, and a binding-defective MDM2 mutant failed to degrade p21waf1/cip1.
- MDM2 significantly shortened the half-life of p21waf1/cip1 and promoted degradation of its lysine-free mutant.
- MDM2 suppressed p21waf1/cip1-induced cell growth arrest in p53-deficient cells.
Conclusions:
- MDM2 directly mediates the degradation of p21waf1/cip1 through a ubiquitin-independent proteolytic pathway.
- This interaction reduces p21waf1/cip1 stability, thereby inhibiting its cell cycle regulatory functions.
- MDM2 acts as a direct negative regulator of p21waf1/cip1 stability and function, independent of p53.
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Inhibition of Cdk Activity
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...